Treatments for Alzheimer’s in other countries

I've been reading about this a lot since my husband was diagnosed.
Most countries use common drugs that help with memory and thinking, such as cholinesterase inhibitors (the most commonly used are Donepezil-Aricept, Rivastigmine-Exelon, and Galantamine-Razadyne), and Memantine-Namenda.

However, the newer "disease-modifying" drugs that aim to slow the underlying progression are being approved at different times in different places.

For example, countries like Japan and China have been quicker to approve some of the latest antibody-based medicines, like Lecanemab (Leqembi) and Donanemab (Kisunla).
In the UK and countries in the European Union, these newer treatments might be approved by regulators, but have problems with funding for wider use in public health systems, because they are expensive and their small benefit doesn't seem to be worth the high price.

Besides all that, in China, for example, using herbal remedies and traditional therapies is common. They use Huperzine A, Ginkgo Biloba, and acupuncture as a normal part of healthcare.

Western countries look at these methods as "alternative" and don't include them in treatment.

If you need more details, feel free to ask

Most countries use the common drugs that help with memory and thinking, like cholinesterase inhibitors: Donepezil- Aricept(most commonly prescribed), Rivastigmine- Exelon and Galantamine- Razadyne. On top of that, there is Memantine- Namenda, which is often prescribed at later stages of Alzheimer's.

However, the newer "disease-modifying" drugs that aim to slow the progression of te disease are being approved at different times and in different places.

For example, countries like Japan and China have been quicker to approve some of the latest antibody-based treatments like Lecanemab (Leqembi) and Donanemab (Kisnula).

In the UK and countries in the European Union, these treatments might be approved by regulators, but have problems with funding for wider use, because they are expensive and their small benefit doesn't seem to be worth the price.

Another difference is that countries like China view herbal remedies and traditional therapies as beneficial. They use Huperzine A, Ginkgo Biloba and acupuncture as part of the therapy for Alz. Western countries(like the US and Europe) see those approaches as "alternative" and don't include them in medical treatment.

Most countries use the common drugs that help with memory and thinking, like cholinesterase inhibitors: Donepezil- Aricept(most commonly prescribed), Rivastigmine- Exelon and Galantamine- Razadyne. On top of that, there is Memantine- Namenda, which is often prescribed at later stages of Alzheimer's.

However, the newer "disease-modifying" drugs that aim to slow the progression of te disease are being approved at different times and in different places.

For example, countries like Japan and China have been quicker to approve some of the latest antibody-based treatments like Lecanemab (Leqembi) and Donanemab (Kisnula).

In the UK and countries in the European Union, these treatments might be approved by regulators, but have problems with funding for wider use, because they are expensive and their small benefit doesn't seem to be worth the price.

Another difference is that countries like China view herbal remedies and traditional therapies as beneficial. They use Huperzine A, Ginkgo Biloba and acupuncture as part of the therapy for Alz. Western countries(like the US and Europe) see those approaches as "alternative" and don't include them in medical treatment.